lobbying_activities: 3051265
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3051265 | d6fc32b1-4034-4db4-a080-7d9ba6ebd1da | Q3 | LUPIN PHARMACEUTICALS INC | 401104766 | LUPIN PHARMACEUTICALS INC | 2023 | third_quarter | CPT | Issues related to patent thickets, patentability standards and IP influencing applications for drug marketing approval. | HOUSE OF REPRESENTATIVES,SENATE | 105000 | 0 | 0 | 2023-10-16T14:17:04-04:00 |